215
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The association between real-time reverse transcriptase polymerase chain reaction cycle threshold values, symptoms and disease severity among COVID-19 patients in the community: a retrospective cohort study

, , , , , & show all
Pages 205-212 | Received 29 Jun 2021, Accepted 19 Oct 2021, Published online: 07 Nov 2021

References

  • Fourati S, Hue S, Pawlotsky JM, et al. SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients. Intensive Care Med. 2020;46(9):1781–1783.
  • Faico-Filho KS, Passarelli VC, Bellei N. Is higher viral load in SARS-CoV-2 associated with death? Am J Trop Med Hyg. 2020;103(5):2019–2021.
  • Kociolek LK, Muller WJ, Yee R, et al. Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs. J Clin Microbiol. 2020;59(1):e02593–20.
  • Schwierzeck V, Konig JC, Kuhn J, et al. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 in a Pediatric Dialysis Unit. Clin Infect Dis. 2021;72(2):265–270.
  • Salvatore PP, Dawson P, Wadhwa A, et al. Epidemiological correlates of PCR cycle threshold values in the detection of SARS-CoV-2. Clin Infect Dis. 2020;72(11):e761–e767.
  • Huang JT, Ran RX, Lv ZH, et al. Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(16):2158–2166.
  • Yu X, Sun S, Shi Y, et al. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression. Crit Care. 2020;24(1):170.
  • Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–374.
  • Xia XY, Wu J, Liu HL, et al. Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19. J Clin Virol. 2020;127:104360.
  • Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020; 369:m1443.
  • Lucas C, Wong P, Klein J, Yale IMPACT Team, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463–469.
  • Bryan A, Fink SL, Gattuso MA, et al. SARS-CoV-2 viral load on admission is associated with 30-day mortality. Open Forum Infect Dis. 2020;7(12):ofaa535.
  • Magleby R, Westblade LF, Trzebucki A, et al. Impact of SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019. Clin Infect Dis. 2020;ciaa851.
  • Tan L, Kang X, Ji X, et al. Validation of predictors of disease severity and outcomes in COVID-19 patients: a descriptive and retrospective study. Med. 2020;1(1):128–138 e3.
  • Fajnzylber J, Regan J, Coxen K, Massachusetts Consortium for Pathogen Readiness, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493.
  • Gorzalski AJ, Hartley P, Laverdure C, et al. Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19. J Biomed Res. 2020;34(6):431–436.
  • Pujadas E, Chaudhry F, McBride R, et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8(9):e70.
  • Roltgen K, Powell AE, Wirz OF, et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Sci Immunol. 2020;5:eabe0240.
  • He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–675.
  • Argyropoulos KV, Serrano A, Hu J, et al. Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms. Am J Pathol. 2020;190(9):1881–1887.
  • Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20:2.
  • To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574.
  • Choudhuri J, Carter J, Nelson R, et al. SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality. PLOS One. 2020;15(12):e0244777.
  • Westblade LF, Brar G, Pinheiro LC, et al. SARS-CoV-2 viral load predicts mortality in patients with and without cancer who are hospitalized with COVID-19. Cancer Cell.
  • Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020;9(1):469–473.
  • Eberhardt KA, Meyer-Schwickerath C, Heger E, et al. RNAemia corresponds to disease severity and antibody response in hospitalized COVID-19 patients. Viruses. 2020;12(9):1045.
  • Asai N, Sakanashi D, Ohashi W, et al. Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)? J Infect Chemother. 2021;27(1):117–119.
  • Kimball A, Hatfield KM, Arons M, CDC COVID-19 Investigation Team, et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing Facility – King county, Washington, march 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):377–381.
  • Lee S, Kim T, Lee E, et al. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic Of Korea. JAMA Intern Med. 2020;180(11):1447–1452.
  • Ra SH, Lim JS, Kim GU, et al. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax. 2021;76(1):61–63.
  • Gremmels H, Winkel BMF, Schuurman R, et al. Real-life validation of the panbio COVID-19 antigen rapid test (abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. EClinicalMedicine. 2021; 31:100677.
  • von Elm E, Altman DG, Egger M, STROBE Initiative, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
  • NIH. COVID-19 treatment guidelines. Clinical spectrum of SARS-CoV-2 infection; 2020 [cited 2021 Mar 1]. Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.
  • Hastie T, Tibshirani R. Generalized additive models. Statist Sci. 1986; 1:297–310.
  • Wood SN. Thin plate regression splines. J Royal Statis Soc. 2003;65(1):95–114.
  • CDC. COVID-19. People with certain medical conditions; 2021 [cited 2021 Mar 1]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
  • Rao SN, Manissero D, Steele VR, et al. A systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther. 2020;9(3):573–586.
  • Maltezou HC, Magaziotou I, Dedoukou X, for Greek Study Group on SARS-CoV-2 Infections in Children, et al. Children and adolescents with SARS-CoV-2 infection: epidemiology, clinical course and viral loads. Pediatr Infect Dis J. 2020;39(12):e388-392–e392.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.